Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON20101
NL-OMON20101
Recruiting
Not Applicable

Antiplatetelet therapy in PCI-treated ACS patients: The Rijnmond Collective Cardiology Research (CCR) Observational Study.

Vereniging Cardiologen Club RijnmondEli Lilly NederlandGrootslag 1-5, P.O box 379NL - 3991 RA HoutenTHE NETHERLANDSTel: +31 30 602 58 37 Fax: +31 30 602 58 88 Mob: +31 6 5382 61880 sites4,000 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAcuut coronair syndroomAcute coronary syndrome

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acuut coronair syndroomAcute coronary syndrome
Sponsor
Vereniging Cardiologen Club RijnmondEli Lilly NederlandGrootslag 1-5, P.O box 379NL - 3991 RA HoutenTHE NETHERLANDSTel: +31 30 602 58 37 Fax: +31 30 602 58 88 Mob: +31 6 5382 6188
Enrollment
4000
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Vereniging Cardiologen Club RijnmondEli Lilly NederlandGrootslag 1-5, P.O box 379NL - 3991 RA HoutenTHE NETHERLANDSTel: +31 30 602 58 37 Fax: +31 30 602 58 88 Mob: +31 6 5382 6188

Eligibility Criteria

Inclusion Criteria

  • •1\. Diagnosis with NSTE\-ACS or STEMI and treated with PCI during index hospitalization;
  • •2\. Age above 18 years.

Exclusion Criteria

  • •Intolerance or allergy for aspirin, ticlopidine, clopidogrel or prasugrel.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients TrialProlonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage
NCT03431142Shenyang Northern Hospital7,758
Completed
Phase 4
Reversing Ticagrelor's Effects With Fresh PlateletsCoronary Artery Disease
NCT02201394Icahn School of Medicine at Mount Sinai20
Unknown
Not Applicable
Antiplatelet Therapy in Acute Coronary Syndrome(ACS). Safety and Efficacy of Switching AntiplateletAcute Coronary Syndrome
NCT02500290Fundación Pública Andaluza Progreso y Salud2,000
Unknown
Not Applicable
Use of Ticagrelor in Korean ACS Patients: The BRILIANT KOREA RegistryAcute Coronary Syndrome
NCT02521038Seoul National University Hospital2,000
Unknown
Phase 1
Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease PatientsCoronary Artery Disease
NCT03078257The First Affiliated Hospital with Nanjing Medical University90